MRD / Regn No. : 20260000542 Date : 17/06/2026
Patient Name : Bhupesh Kanti Dev Age & Gender : 61 Yrs. / Male
Contact No. : 9832362855 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (17/Jun/2016) | DYSLIPIDEMIA (17/Jun/2026) | HEART FAILURE STAGE B (17/Jun/2026) | A1G2 DKD (17/Jun/2026) |
Subjective : DM SINCE 2016,SHOULDER PERIARTHRITIS,HX OF SYNCOPE
Objective : NONE
Analysis : TYPE 2 DM,HFPEF MOST LIKLEY,ABNORMAL ECG,DYSLIPIDEMIA
Plan : CARDIOLOGY OPINION - DR ABRAHAM OOMMAN,ADD GLP1RA SGLT2I STATIN  
Salient Investigations : HIGH SENSITIVE C REACTIVE PROTEIN: 0.72 mg/L | TSH : 3.240 mIU/L | ESR: 2 mm/hour | HEMOGLOBIN: 14.4 g/dL | MCH: 29 pg | MCHC: 32 gm % | MCV: 89 fl | PCV: 44 % | PLATELETS: 132 thou cells/ ul | RBC COUNT: 5.0 million/ul | TOTAL COUNT WBC: 6.70 Cells/cmm | FASTING PLASMA GLUCOSE (FPG): 120 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.6 % | POST PRANDIAL GLUCOSE (2HPP): 349 mg/dL | UREA: 31 mg/dL | CREATININE: 1.03 mg/dL | URIC ACID: 3.0 | HDL HIGH DENSITY LIPOPROTEIN: 41 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 130 mg/dL | TGL TRIGLYCERIDE: 97 mg/dL | TOTAL CHO/HDL RATIO: 4.2 | TOTAL CHOLESTEROL: 175 mg/dl | A\G RATIO: 1.40 g/dl | ALBUMIN (SERUM): 4.18 g/dL | ALKALINE PHOSPHOTASE: 81 IU/L | DIRECT BILIRUBIN: 0.20 mg/dl | GAMMA GLUTAMYL TRANSFERASE (GGT): 21 U/L | GLOBULIN: 2.98 g/dl | INDIRECT BILIRUBIN: 0.36 | SGOT (AST): 33 U/L | SGPT (ALT): 31 IU/L | TOTAL BILIRUBIN: 0.56 mg/dL | TOTAL PROTEIN: 7.16 g/dl | MICROALBUMIN CREATININE RATIO: 15.96 mcg/mg | VLDL: 19 mg/dl | CALCIUM: 9.0 mg/DL | BICARBONATE: 25 meq/L | CHLORIDE: 105 meq/L | POTASSIUM: 5.5 meQ/L | SODIUM: 139 meq/L | CUP DISC RATIO L: 0.54 | CUP DISK RATIO R: 0.47 | ABI LEFT: 0.87 | ABI RIGHT: 0.90 | EGFR EGLOMERULAR FILTRATION RATE: 78.11 mL/min/1.73m2 | FIB4: 2.74 | EGFR EGLOMERULAR FILTRATION RATE: 78.11 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 78.11 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 78.11 mL/min/1.73m2 | FIB4: 2.74 | FIB4: 2.74
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION SEMAGLUTIDE
SEMATRINITY 0.25
Medicine For DIABETES HEART AND KIDNEY PROTECTION 		SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
MAY CAUSE NAUSEA VOMITING OR VISUAL DISTURBANCES
2 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION 		PO 1-0-0 BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
3 ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL 		PO 0-0-1 AT BEDTIME
 TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
       
Refill : 0 / Substitution:    
Education : AVOID CONJEE SWEETS CHOCOLATES AND SIMPLE SUGARS OF ANY KIND,AVOID OR REDUCE RESTAURANT FOOD,AVOID PROCESSED FOOD,EXERCISE 150 MINUTES PER WEEK,REDUCE CARBOHYDRATE BY 20%,REDUCE SEDENTARY TIME
Next Visit : 17/Jul/2026
Tests Suggested For Next Visit : FBS 2HPP
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: